Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3754655
Max Phase: Preclinical
Molecular Formula: C54H76N14O10
Molecular Weight: 1081.29
Molecule Type: Protein
Associated Items:
ID: ALA3754655
Max Phase: Preclinical
Molecular Formula: C54H76N14O10
Molecular Weight: 1081.29
Molecule Type: Protein
Associated Items:
Canonical SMILES: CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C1=O
Standard InChI: InChI=1S/C54H76N14O10/c1-3-4-18-38(61-32(2)69)47(72)66-42-30-45(70)58-24-11-10-20-37(46(55)71)62-50(75)41(29-34-31-60-36-19-9-8-17-35(34)36)64-48(73)39(21-12-25-59-54(56)57)63-49(74)40(28-33-15-6-5-7-16-33)65-51(76)43-22-13-26-67(43)53(78)44-23-14-27-68(44)52(42)77/h5-9,15-17,19,31,37-44,60H,3-4,10-14,18,20-30H2,1-2H3,(H2,55,71)(H,58,70)(H,61,69)(H,62,75)(H,63,74)(H,64,73)(H,65,76)(H,66,72)(H4,56,57,59)/t37-,38-,39-,40+,41-,42-,43-,44-/m0/s1
Standard InChI Key: IKLKELALFPRDEI-NFVVVWSGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1081.29 | Molecular Weight (Monoisotopic): 1080.5869 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Carotenuto A, Merlino F, Cai M, Brancaccio D, Yousif AM, Novellino E, Hruby VJ, Grieco P.. (2015) Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor., 58 (24): [PMID:26599352] [10.1021/acs.jmedchem.5b01285] |
Source(1):